INTENT Biologics, a clinical-stage biotechnology company developing PEP Biologic as the first-in-class exosome-based biologic therapies for serious conditions with significant unmet medical need, ...

The guidance was released by the American Academy of Pediatrics.

Systematic review finds convection-enhanced delivery in pediatric patients is linked mainly to low-grade adverse events, with no Grade 4 or 5 toxicity, supporting safer investigational CNS therapy ...

Please provide your email address to receive an email when new articles are posted on . Supplementing pregabalin and topiramate with vitamin B2 or D enhanced their efficacy for preventing pediatric ...

Allo-HSCT significantly improved survival in real-world pediatric AML, with CR1 patients showing the best outcomes, achieving OS and DFS rates of 84.2% and 73.4%. Matched sibling and unrelated donors ...

EDs can meet pediatric needs by adopting updated readiness standards that reduce mortality and improve care, per national healthcare groups.

Bayer revealed first results of the pediatric study from the pivotal clinical development program QUANTI for its low-dose MRI contrast agent QUANTI Pediatric evaluated the pharmacokinetics and safety ...

Hospital-led Solutions to a Growing Crisis report outlines five hospital case studies showing how systems are integrating ...

Lisa Venghaus, PhD, LPC-S, LMFT-S, Clinical Rater with BioBehavioral Research of Austin (BBRA) stopped by Studio 512 to talk about what BBRA does, and her current work. Lisa says, “BioBehavioral ...

Emergency departments (EDs) that saw fewer kids were more likely to have potentially delayed diagnoses for serious acute conditions in that population, a large retrospective cohort study showed. For ...

Fig 1 Thematic divergence and convergence. Venn diagram demonstrating thematic divergence and convergence among sites. Fig 2 Stigma model for pediatric cancer. Stigma model adapted from the Health ...